Mohamed Abdelnabi, PhD, is a postdoctoral associate at the University of Calgary specializing in spatial omics and liver disease biology. His research focuses on sex-specific liver zonation and fibrosis progression in metabolic-associated steatotic liver disease (MASLD), integrating advanced spatial transcriptomics with computational bioinformatics approaches. He has authored peer-reviewed publications on sex differences in cytokine signaling, including IL-22, particularly in MASLD, with implications for precision medicine and risk stratification. He holds postdoctoral fellowships from the Cumming School of Medicine and the Snyder Institute for Chronic Diseases. His work also explores the spatial landscape and functional roles of immune cells, including neutrophils and macrophages, in liver injury, fibrosis, and tumor biology.